HomeCompareADXS vs SPHD

ADXS vs SPHD: Dividend Comparison 2026

ADXS yields 331.37% · SPHD yields 4.30%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ADXS wins by $2987.28M in total portfolio value
10 years
ADXS
ADXS
● Live price
331.37%
Share price
$0.60
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2987.30M
Annual income
$1,874,518,858.21
Full ADXS calculator →
SPHD
SPHD
● Live price
4.30%
Share price
$49.61
Annual div
$2.14
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26.5K
Annual income
$567.37
Full SPHD calculator →

Portfolio growth — ADXS vs SPHD

📍 ADXS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodADXSSPHD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ADXS + SPHD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ADXS pays
SPHD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ADXS
Annual income on $10K today (after 15% tax)
$28,166.68/yr
After 10yr DRIP, annual income (after tax)
$1,593,341,029.48/yr
SPHD
Annual income on $10K today (after 15% tax)
$365.92/yr
After 10yr DRIP, annual income (after tax)
$482.26/yr
At 15% tax rate, ADXS beats the other by $1,593,340,547.21/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ADXS + SPHD for your $10,000?

ADXS: 50%SPHD: 50%
100% SPHD50/50100% ADXS
Portfolio after 10yr
$1493.66M
Annual income
$937,259,712.79/yr
Blended yield
62.75%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ADXS right now

ADXS
Analyst Ratings
6
Buy
2
Hold
Consensus: Buy
Altman Z
-24.8
Piotroski
1/9
SPHD
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ADXS buys
0
SPHD buys
0
No recent congressional trades found for ADXS or SPHD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricADXSSPHD
Forward yield331.37%4.30%
Annual dividend / share$2.00$2.14
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$2987.30M$26.5K
Annual income after 10y$1,874,518,858.21$567.37
Total dividends collected$2879.16M$5.0K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: ADXS vs SPHD ($10,000, DRIP)

YearADXS PortfolioADXS Income/yrSPHD PortfolioSPHD Income/yrGap
1← crossover$43,837$33,137.27$11,130$430.50+$32.7KADXS
2$182,667$135,761.45$12,357$447.82+$170.3KADXS
3$724,155$528,700.93$13,687$464.65+$710.5KADXS
4$2,733,677$1,958,830.81$15,126$480.98+$2.72MADXS
5$9,835,841$6,910,807.10$16,682$496.78+$9.82MADXS
6$33,762,918$23,238,567.70$18,362$512.03+$33.74MADXS
7$110,677,420$74,551,098.17$20,174$526.72+$110.66MADXS
8$346,821,277$228,396,437.05$22,127$540.84+$346.80MADXS
9$1,039,984,991$668,886,225.19$24,230$554.39+$1039.96MADXS
10$2,987,302,799$1,874,518,858.21$26,493$567.37+$2987.28MADXS

ADXS vs SPHD: Complete Analysis 2026

ADXSStock

Ayala Pharmaceuticals, Inc., a clinical-stage oncology company, primarily focuses on developing and commercializing small molecule therapeutics for people living with rare tumors and aggressive cancers. The company's lead candidates under development include AL102, an oral gamma secretase inhibitor for desmoid tumors; and aspacytarabine (BST-236), a novel proprietary anti-metabolite for first line treatment in unfit acute myeloid leukemia. Ayala Pharmaceuticals, Inc. is based in Wilmington, Delaware.

Full ADXS Calculator →

SPHDETF

The Invesco S&P 500 High Dividend Low Volatility ETF (Fund) is based on the S&P 500 Low Volatility High Dividend Index (Index). The Fund will invest at least 90% of its total assets in common stocks that comprise the Index. Standard & Poor's compiles, maintains and calculates the Index, which is composed of 50 securities traded on the S&P 500 Index that historically have provided high dividend yields and low volatility. The Fund and the Index are rebalanced and reconstituted semi-annually, in January and July.

Full SPHD Calculator →
📬

Get this ADXS vs SPHD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ADXS vs SCHDADXS vs JEPIADXS vs OADXS vs KOADXS vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.